Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Clinical trial NCT01909388 · UNKNOWN

Trial details

NCT number: NCT01909388
Sponsor: Alfonso Gomez-Iturriaga
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2013-06-01
Primary completion: 2014-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.